Prostatype Genomics AB Statistics
Total Valuation
STO:PROGEN has a market cap or net worth of SEK 82.33 million. The enterprise value is 81.94 million.
| Market Cap | 82.33M |
| Enterprise Value | 81.94M |
Important Dates
The next confirmed earnings date is Thursday, February 11, 2027.
| Earnings Date | Feb 11, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:PROGEN has 560.09 million shares outstanding.
| Current Share Class | 560.09M |
| Shares Outstanding | 560.09M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +201.07% |
| Owned by Insiders (%) | 3.22% |
| Owned by Institutions (%) | n/a |
| Float | 541.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 81.20 |
| PB Ratio | 12.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 80.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.34 |
Financial Efficiency
Return on equity (ROE) is -176.16% and return on invested capital (ROIC) is -108.81%.
| Return on Equity (ROE) | -176.16% |
| Return on Assets (ROA) | -55.91% |
| Return on Invested Capital (ROIC) | -108.81% |
| Return on Capital Employed (ROCE) | -572.07% |
| Weighted Average Cost of Capital (WACC) | 11.98% |
| Revenue Per Employee | 144,857 |
| Profits Per Employee | -5.41M |
| Employee Count | 7 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 139.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.08% in the last 52 weeks. The beta is 1.41, so STO:PROGEN's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -75.08% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 47.01 |
| Average Volume (20 Days) | 12,524,287 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:PROGEN had revenue of SEK 1.01 million and -37.90 million in losses.
| Revenue | 1.01M |
| Gross Profit | -16.94M |
| Operating Income | -37.46M |
| Pretax Income | -37.90M |
| Net Income | -37.90M |
| EBITDA | -35.27M |
| EBIT | -37.46M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 392,000 in cash and no debt, with a net cash position of 392,000 or 0.00 per share.
| Cash & Cash Equivalents | 392,000 |
| Total Debt | n/a |
| Net Cash | 392,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.55M |
| Book Value Per Share | n/a |
| Working Capital | -32.03M |
Cash Flow
In the last 12 months, operating cash flow was -20.90 million and capital expenditures -61,000, giving a free cash flow of -20.96 million.
| Operating Cash Flow | -20.90M |
| Capital Expenditures | -61,000 |
| Depreciation & Amortization | 2.19M |
| Net Borrowing | 11.50M |
| Free Cash Flow | -20.96M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,694.18% |
| Pretax Margin | -3,737.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:PROGEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -46.04% |
| FCF Yield | -25.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 31, 2024. It was a reverse split with a ratio of 0.001.
| Last Split Date | Oct 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.001 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |